Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Brand-name prescription medicine

Amphotericin B liposome

Generic name: Amphotericin b

FDA application holder: Mylan Labs Ltd

Strengths and generic versions

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

1Strengths and forms
0Same medicine, other names
2025FDA approval
0Recalls (FDA reports)

Quick answers

What is Amphotericin B liposome?
Amphotericin B liposome is a brand name of Amphotericin b, a prescription medicine. The FDA NDC Directory lists 1 Amphotericin B liposome product in 1 strength and form.
Who makes Amphotericin B liposome?
Mylan Labs Ltd holds the FDA application for Amphotericin B liposome (ANDA212967, approved June 30, 2025).
Is there a generic or store brand of Amphotericin B liposome?
Other products of Amphotericin b are listed with the FDA, but none in exactly the same strength and form as a Amphotericin B liposome product.
Has Amphotericin B liposome been recalled?
No recall linked to Amphotericin B liposome products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Amphotericin B liposome is

Each Amphotericin B liposome product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Amphotericin b · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
amphotericin b 50 mg/12.5 mL
injection, powder, lyophilized, for suspension (intravenous)		 Amphotericin B liposome None listed —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Amphotericin b →

FDA approval

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
FDA applications of Amphotericin B liposome products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
ANDA212967Mylan Labs LtdJune 30, 20251

Companies that list Amphotericin B liposome

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Amphotericin B liposome products.

Recalls

No recall linked to Amphotericin B liposome products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers